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The  mechanism  that underlies anaphylactic shock  in mice has not, as yet, 
been determined. The organ or organs most concerned are not known. Nor has 
there been a  definite identification of a  chemical mediator. 
It is doubtful that histamine plays a significant role in bringing about the reaction. 
Mice are extremely insensitive to histamine (1-3) and much less than a toxic amount 
of histamine is present in  the normal mouse  (1).  In addition, antihistamine drugs, 
which  completely protect guinea pigs, do not protect the mouse from anaphylactie 
shock (3). These drugs also fail to influence the contraction, in vitro, of uterine strips 
from sensitized mice, in response to antigen (Schultz-Dale reaction, 4), though they 
do  antagonize  the  effects of histamine.  The  uterus  is also relatively insensitive to 
histamine. 
Since the release of histamine probably does not play a  significant role in mouse 
anaphylaxis, much  attention  has  recently been  directed  to  the  possibility that  5- 
hydroxytryptamine (serotonin) might mediate the reaction. In vitro studies, using the 
Schultz-Dale reaction  as  an  indicator of  anaphylaxis, have  provided  some  of  the 
evidence implicating serotonin. The mouse uterus is much more sensitive to serotonin 
than to histamine, and the contraction that usually follows administration of antigen 
is blocked by antimetabolites of  serotonin,  such  as lysergic acid diethylamide and 
reserpine (5). Prior treatment of mice with these compounds or with other antimetabo- 
lites of serotonin (6-8) protects mice against lethal anaphylactic shock. In addition, 
serotonin has been  shown  to  be liberated from  rabbit  (7),  though  not  mouse  (10) 
platelets during anaphylactic shock.  Finally, serotonin administration to  mice  (11) 
and  to guinea pigs (12)  mimics anaphylaxis. 
Serotonin release, however, has not definitely been shown to be the cause of anaphy- 
lactic shock in mice. Analyses of the serotonin content of blood and tissues of animals 
dying in anaphylactic shock did not reveal significant differences from similar analyses 
in control animals (10).  This finding does not eliminate serotonin as a  possible toxic 
agent in mouse anaphylaxis. There is a wide variation in the normal serotonin content 
of  tissues  among  individual mice,  so  that  lethal  amounts  of  serotonin  could  con- 
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ceivably be released at particularly effective sites and still go undetected by analyses 
of blood and  tissues in many animals  (13).  Still, the evidence which implicates sero- 
tonin is indirect. It comes mainly from in vitro studies,  and  from studies using sero- 
tonin  antimetabolites. 
There is a considerable amount of evidence that indicates that the enterochromaffin 
(argentaffin)  cells of the gastrointestinal  tract represent a  serotonin depot.  Serotonin 
has been identified in high concentration in tissues rich in these cells (14,  15). Tumors 
(carcinoid)  of  enterochromaffin  cells contain  large  amounts  of  serotonin  (16).  The 
histochemical reactions of these cells are similar to those of serotonin models (17,  18). 
Reserpine  causes  a  release  of  serotonin  from  the gut which  parallels  a  depletion of 
enterochromaflin  substance  (18).  Lillie,  however,  pointing  to  the negative reaction 
shown by these cells for indoles, maintained that serotonin is unlikely to be the entero- 
chromaffin  substance  (19).  Other  investigators  have  attributed  the  absence  of  an 
indole reaction to formalin fixation (17,  18). 
In  the present  study  several  lines of  evidence are  presented  which  support 
the hypothesis that release of serotonin is causally related to mouse anaphylaxis. 
Substances which cause the depletion of serotonin  stores render mice refractory 
to  anaphylactic  shock.  Serotonin-depleting  procedures  also  cause  a  depletion 
of  enterochromaffin  substance,  a  depletion  which  is  also  observed  after 
anaphylactic shock.  Further,  the amount of enterochromaffin substance present 
correlated  well with  the  susceptibility  of mice to  anaphylactic  shock.  Finally, 
the behavior of mice undergoing anaphylactic shock is similar to that following 
procedures known  to release serotonin. 
Materials and Methods 
Animals.--A strain  of mice derived originally from the  DBA/2 and  the BALB/c (Bar 
Harbor)  and bred for 4 years in this laboratory was used. The animals were equally divided 
between the sexes and averaged 22 gm in weight. 
Antigen.--Three  antigens,  diphtheria  and  tetanus  toxoids,  and  pertussis  vaccine  com- 
bined  (DPT)  were used  to sensitize and  to challenge mice. Aluminum phosphate  adsorbed 
product (tri-immunol) was obtained from Lederle Laboratories.  Fluid DPT  (tridipigen) was 
obtained from Eli Lilly and Company and material of the same lot number was used through- 
out. 
Method of Sensitization.--Arfimals were  sensitized  by  three  subcutaneous  injections  of 
DPT,  all of 0.1  cc.  The  first injection was of the aluminum phosphate  adsorbed  product. 
The second  and third sensitizing injections were of fluid DPT. The second injection followed 
2 weeks after the first and the third injection was given 1 to 2 weeks after the second.  Ana- 
phylacfic shock was produced by intravenous challenge with fluid DPT exactly 1 week follow- 
ing the third sensitizing dose.  The antigen used for challenge was diluted to maintain a con- 
stant  ratio of volume to weight of mouse.  A dose of antigen, 0.03  cc/gm, which was larger 
than the maximal amount of antigen used for challenge was shown to be non-toxic to a con- 
trol series  of thirty non-sensitized mice. Deaths following a  challenge dose of antigen were 
therefore considered to be due to anaphylactic shock and were counted for 24 hours after the 
injection of DPT. 
Drugs and Chernlcals.--All drugs  were dissolved in physiological saline unless otherwise 
noted. 
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to mice by intravenous injection v/a the tail vein. Amounts given are expressed as mg/kg, 
but concentrations were chosen to maintain a  constant ratio of volume to weight of mouse. 
2.  Reserpine  (obtained through the courtesy of Ciba Pharmaceutical Co., Summit, New 
Jersey) was given intraperitoneaily in doses of 5 mg/kg. 
3.  ~-TM10  (SKF 6890,  2-(2-(6-dimethylphenoxy)propyl)  trimethyl ammonium  chloride 
monohydrate,  obtained  through  the  courtesy  of  Smith,  Kline  and  French  Laboratories, 
Philadelphia) was given subcutaneously,  in four doses of 150 mg/kg each, over a  period of 
3 days. The final dose was given 1 hour prior to challenge with DPT. 
4.  Norepinephrine  (Winthrop  Laboratories,  New York)  was given subcutaneously  in a 
dose of 0.01 nag in 0.5  cc solution immediately following challenge with DPT. 
5.  L-a-methyl  dopa  (3,4-dihydroxyphenyl-l-a-methylalanine,  generously  supplied  by 
Merck Sharp  & Dohme, West Point, Pennsylvania) was suspended in a  solution contninlng 
75  mg/cc  of polyvinylpyrrolidinone  (Matheson,  Coleman  and  Bell,  Cincinnati)  in  physi- 
ological saline.  Polyvinylpyrrolidinone was included in order to provide a  sustained release 
of 1-a-methyl dopa from its site of subcutaneous  injection (20). r-a-methyl dopa was given 
in a  regimen of nine injections, 400  mg/kg each, at  6 hour intervals.  Challenge with DPT 
followed the final injection by 1 to 2 hours. 
6.  Histamine phosphate  (Nutritional Biochemicals Corp., Cleveland) was given in a dose 
of 750  mg/kg intravenously. 
7.  Compound 48/80 (Burroughs, Wellcome Research Laboratories, Tuckahoe, New York) 
was given in a  dose of 50 mg/kg intravenously. 
8.  JB  516  (catron,  ~-phenyl isopropyl hydrazine  HC1,  generously supplied  by Lakeside 
Laboratories,  Milwaukee)  was given intraperitoneally in a  dose of 60 mg/kg. 
9.  5-Hydroxytryptophane  (Sigma)  was given intraperitoneally in a dose of 50 mg/kg. 
Histological Techniq,te.--Tissues were fixed in 10 per cent formalin at pH 4.5 for at least 
48 hours.  The tissues were then washed in water,  dehydrated  in ethanol,  cleared in cedar- 
wood oil and benzene, and embedded in paraffin. Enterochromafl~n  cells were demonstrated 
by the methenamine silver method of Gomori and Burtner cited in reference 21 and the ferric 
ferricyanide method  of Lillie and  Burtner  (22).  The  two  methods  showed  approximately 
the same numbers of cells on alternate  serial sections. 
EXPERIMENTAL  OBSERVATIONS 
E~ects of the Antigen.--Pertussis  vaccine has been shown to increase the 
susceptibility  of mice to serotonin, to histamine, and when combined with 
other antigens,  to anaphylactic shock (2, 3, If, 24-26). V~'nile  in some strains 
of  mice an increased  susceptibility  to  histamine has not followed  administration 
of pertussis  vaccine (27),  no strains  have been reported,  prior  to this  study, in 
which there  has not  been an increase  in  sensitivity  to  serotonin.  Since  this  study 
is concerned with the toxicity  of serotonin and its relation  to anaphylactic 
shock, the effect  of the antigens used on the toxicity  of serotonin was ascer- 
tained. 
The toxicity  of various doses of serotonin  was determined in a series  of non- 
sensitized  control  mice and in animals sensitized  to DPT. Table I shows that 
the lethality  of serotonin did not differ  significantly  between the two groups, 
the 95 per cent confidence limits  of the LDs0 overlap. The antigens used in 
sensitizing  this  strain  of mice, therefore,  did not alter  the sensitivity  of these 
animals to serotonin. 
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cause the release and subsequent depletion  of stores of serotonin and catechol 
amines  (28)  and  to protect  mice from anaphylactic  shock  (6,  7).  As seen  in 
Table I, reserpine does not alter the toxicity of serotonin. The following experi- 
ments were designed  therefore,  to investigate  the means whereby reserpine  is 
able  to  prevent  lethal  anaphylaxis  and,  in  particular,  whether  its  ability  to 
deplete serotonin or catechol amines is responsible. 
Animals were sensitized to DPT and separated into several groups. The lethality of various 
doses of DPT was determined in a control group of mice receiving no additional  treatment. 
The lethality  of DPT was then determined  for experimental  mice receiving various  treat- 
ments in addition to challenge with DPT. Comparisons were made with the control groups 
and the effects of these treatments  on anaphylactic shock were thereby assessed. 
TABLE I 
Effect of Sensitization to DPT and the Administration of Reserpine on the Lethaht~ 
Treatment 
Control mice--not sensitized to antigen  (DPT)., 
Mice sensitized  to  antigen  (DPT)  challenged 
with  serotonin  1 week after  third  sensitizing 
dose ...................................... 
Mice sensitized  to  antigen  (DPT)  and  given 
reserpine 48 and 24 hours  prior  to challenge 
with serotonin ............................ 
No. of animals 
79 
78 
58 
LD60* expres- 
sed as mg/kg 
serotonin given 
intravenously 
245 
245 
260 
of Serotonin 
95 per cent 
confidence 
limits of LD~0 
219-275 
221-272 
229--296 
* Determined by the method of Litchfield and Wilcoxon (23). 
Three groups of mice received reserpine. One group was given two doses of reserpine 48 
and 24 hours prior to challenge with DPT. Another group received one dose 48 hours prior 
to challenge. The third group received one dose 30 minutes before challenge with DPT. 
The results,  which are summarized in Table II,  confirm that reserpine  does 
protect against anaphylactic shock. It does not do so, when it is given shortly 
before challenge with DPT. Reserpine has essentially disappeared from tissues 
24 hours  after injection  (28).  Mice are therefore protected  from anaphylactic 
shock after the administration of reserpine at a  time when the drug itself is no 
longer present in the animal. Moreover, there is a time delay after the injection 
of reserpine before the protective effect develops. With respect  to  these  char- 
acteristics  the protective action of reserpine  parallels  its  amine-depleting  and 
sedative  actions.  Thus, it is probable  that  the ability of reserpine  to prevent 
lethal  anaphylaxis is owing to an indirect,  delayed action of reserpine,  such as 
amine depletion, rather than to a  direct effect of the drug itself. 
In order  to examine  the possible  role  that  catechol amine  depletion  might 
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were given to mice. TM10 has been shown to deplete catechol amines from the 
adrenal medulla (29) and to prevent the release of catechol amines from sym- 
pathetic nerve endings upon stimulation of the nerve (30)./~-TM10, a congener 
of TM10,  has been shown  to have the same sympatholytic effects as TM10 
(but  is  devoid  of muscarinic side  effects)  (30).  As can  be seen in  Table  II, 
/3-TM10  did  not  significantly  protect  mice  from  anaphylactic  shock.  Nor- 
epinephrine,  however, given at  the time of challenge,  did afford a  slight but 
Effect of Reserpine, 
Treatment 
Control 
Reserpine, 48  and  24  hrs. 
prior to chellenge. 
Reserpine, 48 hrs. prior to 
challenge. 
Reserpine, 30 rain. prior to 
challenge. 
3-TM 10 for 3 days prior to 
challenge. 
Norepinephrine at  time  of 
challenge. 
TABLE II 
3-TM 10 and Norepinephrine on Anaphylactic Shock 
No. of 
animals 
71 
60 
40 
43 
60 
30 
Deaths/No. of animals in group at various 
doses of antigen  (DPT) in sensitized 
mice, cc/gm 
0.~2 
0/11 
0.004 
4/15 
0/15 
5/12 
2/15 
0.012 
10/15 
0/15 
0/12 
12/15 
11/15 
2/155 
0.020 
15/15 
0/15 
5/28 
16/16 
14/15 
10/15§ 
0.028 
15/15 
0/15 
15/15 
LD6o* with 95 per 
cent confidence  limit! 
0.OO77  (0.0054- 
0.0116) 
0.0052  (0.0034- 
0.0075) 
0.0090  (0.0050- 
0.0162) 
* Determined by the method of Litchfield and Wilcoxon (23). 
0.05 >  p-compared by means of a (Chi)  ~ test with control results. 
§ 0.02 >  p. 
significant degree of protection. It has already been reported that epinephrine 
protects mice from anaphylactic shock (7). Catechol amines may therefore be 
looked upon as protective substances in the case of mouse anaphylaxis. Thus, 
the depletion of these amines by reserpine  would be more likely to enhance 
rather than to prevent anaphylactic shock. The finding that/3-TM10 does not 
protect against anaphylactic shock supports this view. 
Effect of L-a-Methyl Dopa on Anaphylactic Shock.--L-a-methyl dopa inhibits 
the decarboxylafion of aromatic amino acids (31,  32). It will therefore prevent 
the  synthesis  of  serotonin  from  its  precursor  5-hydroxytryptophane  by  in- 
hibiting  the  enzyme,  5-hydroxytryptophane  decarboxylase  (32-34).  If  it  is 
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results (34). It will also deplete catechol amines. In these ways L-a-methyl dopa 
resembles reserpine.  The two drugs  do not resemble each other,  however, in 
chemical structure or in the mechanism by which they cause serotonin deple- 
tion.  Reserpine  produces  serotonin  depletion  most probably by  causing  the 
release of bound serotonin to the free form from which it may subsequently be 
metabolized (28). 
As can be seen in Table III, L-a-methyl dopa protects mice from anaphylactic 
shock when it is given over a period of time long enough to produce a depletion 
of stores of serotonin  (34).  These two drugs  therefore,  L-a-methyl dopa  and 
reserpine, which are known to be similar only in their ability to deplete amines, 
both protect against  anaphylactic  shock.  Reserpine,  which  is  a  more potent 
serotonin depletive than L-a-methyl dopa (28,  34) provides greater protection. 
Enterochromaflin  Cells  and Anaphylactic  Shock.--The  presence  of  granules 
of enterochromaffin substance is necessary for the histochemical demonstration 
TABLE III 
Effect of L-a-Methyl Dopa on Anaphylactic Shock 
Dose of antigen (DPT) 
co~gin 
0.020 
0.012 
Lethality of challenge with antigen deaths/No, of animals in  group 
a-Methyl Dopa 
5/15 
4/15 
Control 
15/15 
10/15 
p* 
0.001 >  p 
0.05  >  p 
* Determined by (Chi)  2 test. 
of the enterochromaffin cells.  Therefore a loss of enterochromaffin substance is 
reflected in histological slides as a  loss of cells.  The number of duodenal entero- 
chromaffin cells was therefore determined in control  sensitized mice, in mice 
subjected  to  anaphylactic  shock,  and  after  various  other  procedures.  No 
attempt  was  made  to  grade  depletion  of  enterochromaffin substance  within 
individual cells,  so that only the loss of enough enterochromaffin substance to 
prevent the staining of cells could be detected. 
A great deal of variation in the number of enterochromaffin cells along the 
gastrointestinal tract was observed. However, there was a uniform distribution 
of cells  in  the  segment of duodenum  between  the pyloric sphincter  and  the 
entrance  of the pancreatic  duct.  The number of cells in  this region  was also 
relatively constant  between  animals and  this  was  seen  to be a  zone of high 
concentration of the cells.  A 2 mm section of duodenum from this region was 
always selected for histochemical examination. The duodenum was oriented so 
that  seriall  cross-sections  could  be  cut.  250  sections,  8  micra in  thickness, 
were cut, enterochromaffin cells demonstrated, and the number of cells in every 
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The number of enterochromaffin cells was greatly diminished in mice after 
anaphylactic  shock,  indicating  release  and  depletion  of  enterochromaffin 
substance (Figs. 1 and 2). Reserpine, as expected (18), depleted the cells, but, 
unexpectedly, serotonin did also. Depletion of these cells seems to be a specific 
response  since  the  number  of  cells  was  not  significantly diminished  after 
several non-specific stressful procedures. These included the subjection of mice 
to cold, fatigue, and drowning, by first storing them at 5°C for 2 hours, and then 
forcing them to swim in water at that temperature until they fatigued and 
drowned. Mice were also given lethal doses of histamine and 48/80, the latter 
a  substance  that causes  the  degranulation of mast  cells  with  a  consequent 
release of serotonin and histamine from these cells (35, 36). 
TABLE  IV 
Enterochromafin Cell Counts 
Treatment 
Control ......................... 
Anaphylaetic shock ............... 
150 mg/kg serotonin .............. 
5  mg/kg reserpine in two doses 24 
hrs. apart ..................... 
750 mg/kg histamine ............. 
Cold, fatigue, and drowning ....... 
50 mg/kg 48/80 .................. 
Mean No. 
of enterochro- 
maffin cells 
counted in 
samples of 
50 sections 
15,204 
4,948 
8,496 
7,814 
15,983 
12,871 
15,365 
95 per cent 
confidence Umlts 
of the mean 
16,907-13,501 
5,875--4,021 
11,460-5,532 
7,872-7,756 
16,976-14,990 
14,142-11,600 
20,197-10,533 
Estimated No, 
of enterochro- 
maffin cells in 
whole 2 mm of 
duodenum 
76,019 
24,738 
42,482 
39,073 
79,916 
64,355 
76,827 
No.  of 
animals 
counted 
10 
5 
5 
The  Effect  of  Enterochromajfin  Cell-Depleting  Substances  on  Anaphylactic 
Shock.--Both  serotonin and  reserpine  cause  enterochromaffin cell depletion. 
Reserpine  can  protect  mice  from  lethal  anaphylactic  shock.  Therefore,  in 
order to study the possible relationship between enterochromaffin cell depletion 
and protection against anaphylactic shock,  the  effect of serotonin on lethal 
anaphylaxis was determined. In addition, the time course of the recovery of 
enterochromaffin cells after reserpine injection, was correlated with the return 
of susceptibility to anaphylactic shock. Results are summarized in Table V. 
Sensitized mice were challenged with DPT 3 and 4 hours after having received 
an intravenous dose of serotonin. The dose of serotonin, 150 mg/kg, was sub- 
lethal (no deaths in 15 sensitized mice), but was able to cause enterochromaffin 
cell depletion. Mter 3 hours, as can be seen in Table V, prior treatment with 
serotonin provided good but only partial protection against anaphylactic shock. 
After 4 hours, however, protection was complete. 
48 hours after a single injection of reserpine, the number of enterochromaffin 
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however, when the enterochromaffin cell counts had returned  to about 80 per 
cent of normal, the ability of treated mice to undergo anaphylactic shock had 
similarly  returned.  A  correlation  has  been  demonstrated  therefore  between 
numbers  of enterochromaffin  cells  and  susceptibility  of mice to anaphylactic 
shock. 
The  Effect  of Sublethal  Doses  of Antigen  on  the  Toxicity  of Serotonin.  The 
observations that sublethal doses of serotonin were able to cause the depletion 
of enterochromaffin cells and to  protect  mice  from anaphylactic  shock,  seem 
TABLE V 
Enterochromaffin Cell Counts and Susceptibility to Anaphylactic Shock 
Treatment 
Control. 
150 mg/kg serotonin. 
150 mg/kg serotonin 
5.0 mg/kg reserpine. 
5.0 mg/kg reserpine. 
5.0 mg/kg reserpine. 
5.0 mg/kg reserpine followed  after 48 
hrs. by 1-a-methyl dopa. 
Time between 
first treatment 
and  subsequent 
challenge  with 
antigen 
~lrs. 
3 
4 
48 
72 
108 
113 
Mean No. of 
argentaffin cells  in 
50 section  samples 
15,204  (10)* 
8,496  (5) 
8,496  (5) 
9,114  (3) 
12,806  (5) 
Deaths/No. of animal~ 
in group at  two  doses 
antigen (DPT) in sensl 
tized mice, co~gin 
0.012  0.020 
10/15  ~  15/15 
3/15  i 
0/15~  0/15~ 
0/12  1  5/28~ 
i  7/15 
1  22/26 t 
4/15j 
I 
* Numbers in parentheses refer to the number of animals in the group for which the mean 
was determined. 
:~ Compared by means of a  (Chi)  2 test with  the results  obtained  from control  animals. 
(o.ool  >  p) 
§ These results were compared with each other by means of a (Chi)  2 test.  (0.001 >  p) 
at first, to conflict with the serotonin-release hypothesis of anaphylaxis.  It was 
of interest,  therefore, to determine whether the toxicities of serotonin and anti- 
gen are additive in sensitized mice, as would be predicted from the serotonin- 
release  hypothesis. 
A  sublethal  dose of antigen,  0.002 cc/gm,  (see Table II), was given to sen- 
sitized mice. 30 minutes later they were challenged with serotonin. The results 
of this experiment, summarized in Table VI, show that the injection of antigen 
prior to a  dose of serotonin does increase the toxicity of the serotonin.  A  sum- 
mation  between  the  lethality  of antigen  and  serotonin  can  be  demonstrated 
therefore, though we have only been able to observe this when the administra- 
tion of antigen precedes that of serotonin.  It has been reported  (7)  that prior 
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potentiates  passive  anaphylaxis,  and  that  administration  of  serotonin  or  5- 
hydroxytryptophane  abolishes  the  protection  afforded  by  reserpine  against 
passive anaphylaxis. 
The Effect of L-o~-Methyl Dopa on the Return of Susceptibility to Anaphylactic 
Shock after an Injection of Reserpine.---48 hours after a single injection of reser- 
pine, mice were placed on a  9 dose regimen of L-or-methyl dopa. The animals 
were then challenged with DPT 55 hours after the first injection of L-a-methyl 
dopa, and 113 hours after the injection of reserpine. As can be seen from Table 
V, L-a-methyl dopa prevented the return of susceptibility of the mice to ana- 
phylactic shock, which ordinarily follows 108 hours after injection of reserpine. 
The lethality of DPT remained at about the same level that would be expected 
48  hours  after a  single dose  of reserpine  when  administration  of L-a-methyl 
TABLE VI 
The Effect of Prior Treatment with Antigen on Serotonin Lethality 
TJ eatm~  t 
Control--mice sensitized to antigen (DPT) ...... I 
0.002 co/gin DPT given to sensitized mice 30 min. [ 
prior to challenge with serotonin .............  [ 
Total No. of animals 
78 
72 
LD6o* in mg/kg of 
serotonin with 95 per 
cent confidence limits 
245  (221-272) 
190  (176-205) 
* Determined by the method of Litchfield and Wilcoxon (23) 
Note: The ratios of the components, in the case of animals receiving DPT and serotonin, 
to the independently effective doses (LD60 of each drug given alone) total approximately to 
unity  (serotonin, 190/245 =  0.775; DPT, 0.002/0.0077 =  0.259; Sum =  1.034). This indi- 
cates that the toxicity of serotonin and DPT is additive. 
dopa  was  begun.  Thus,  since  L-a-methyl dopa  is  an  inhibitor  of  serotonin 
synthesis, this finding may be taken as evidence that serotonin resynthesis is 
necessary, after its depletion  by reserpine, for the induction  of anaphylactic 
shock. 
Behavioral  Aspects of Anaphylactic Shock.--The behavior of mice undergoing 
anaphylactic shock was studied  and compared with that of animals subjected 
to known serotonin-releasing procedures. The behavior of the animals used in 
this experiment, during anaphylactic shock, was similar to that which has been 
described  in  the  literature  as  early as  1911 (37).  As  a  means  of facilitating 
description,  the  behavioral pattern may be divided  into  three  stages.  For  2 
to 7 minutes following challenge with antigen there is no change in the behavior 
of mice.  Therefore,  though  changes  do  occur in  the  vasculature  of  the  ears 
at  this  time (38),  this stage of anaphylaxis was called  the latent phase.  The 
mice th~n pass through a brief period of hyperactivity, not more than 1 minute 
in length, marked by scratching of the nose (which swells), biting of the anus, 376  5-HYDROXYTRYPTAMINE  IN  MOUSE  ANAPHYLAXIS 
and hyperexcitability to auditory and tactile stimuli. This period ushers in the 
second, or quiet phase, of anaphylactic shock. The animals lie prone, or huddle, 
and  rarely move unless  disturbed.  Breathing  appears  to  be  difficult and  at 
first is rapid and shallow, but becomes deep, forced, and very slow.  The fur is 
ruffled. When forced to move, the animals often have an unsteady gait, and 
some weaken and appear to be unable to support their own weight. Diarrhea 
is almost always seen. This quiet phase of anaphylactic shock is very variable 
in length, and while rarely as brief as 4 minutes, it usually lasts for 10 to 20 
minutes, and sometimes for several hours. Mter sublethal doses of antigen this 
phase tends to be long and animals lie quietly for up to 24 hours. The third, or 
lethal phase of anaphylactic shock is one of prostration. Breathing is irregular 
and gasping in nature. Animals become unresponsive even to painful stimuli. 
Body temperature has fallen and is low. The mice then characteristically roll 
over onto  their  sides,  show  some  convulsive kicking  movements, and  stop 
breathing. The heart continues to beat for some time after breathing has ceased. 
The  second,  or  quiet,  phase  of anaphylactic  shock  resembles  the  sedated 
behavior of  mice  following the  injection of  reserpine.  Thirty animals  given 
reserpine,  5  mg/kg,  each day for 3  days,  were deeply sedated but could be 
roused. They showed an unsteady gait and a fall in body temperature. Diarrhea 
was  prominent.  Since evidence exists,  indicating  that  the sedative effects of 
reserpine  may be  traced  to  serotonin  release  (39),  the  behavioral  similarity 
between anaphylactic shock and reserpine treatment was investigated further. 
It has been reported (40)  that animals pretreated with a monoamine oxidase 
inhibitor  and  then  given  reserpine,  become  agitated  rather  than  sedated. 
These mice mimic the agitated behavior of mice given 5-hydroxytryptophane, 
which penetrates into the brain and is decarboxylated to serotonin. This agita- 
tion is also accentuated if a monoamine oxidase inhibitor is given before 5-hy- 
droxytryptophane (41, 42). Both of these procedures can be interpreted as pro- 
ductive of a high concentration of free serotonin in the brain (42, 43). The effect 
of  a  potent monoamine oxidase inhibitor, JB  516 (44), on anaphylactic shock 
was therefore determined. 
JB 516, given to 60 sensitized mice, 1 to 2 hours before challenge with DPT, 
did not have any effect on the lethality of anaphylactic shock, but it did pro- 
duce a profound change in the behavioral picture. The latent phase of anaphy- 
lactic shock existed as  before, but the  quiet phase  was  abolished.  Rather,  a 
picture of continuing agitation and excitement was seen. Eyes were open wide, 
the animals were hyper-responsive to tactile and auditory stimuli, and the fur 
was ruffled. Body temperature had risen. The mice eventually came to assume 
a characteristic posture with all four legs rigidly extended away from the body. 
The animals  moved their heads  rapidly from side  to  side and  a  generalized 
muscular  tremor  was  seen.  Periodically some  of  the  animals  vocalized  and 
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became mildly hyperactive, but never showed the pattern of agitation which 
accompanied JB  516  and  anaphylactic  shock.  Death  of mice given JB  516 
before a dose of antigen came suddenly, with no preceding phase of prostration. 
The agitated animals became rigid, ceased breathing, and rigor morris followed 
rapidly, often within a minute. An identical pattern of behavior, marked by the 
characteristic posture, was observed in thirty animals receiving  reserpine,  and 
in thirty animals  receiving 5-hydroxytryptophane  1 hour after a  dose of JB 
516. In these cases also, body temperature rose. 
The behavioral pattern of mice undergoing anaphylactic shock bears some 
striking similarities,  therefore, to that of mice treated with reserpine.  In both 
cases,  there is produced a period of sedation and a fall in body temperature. 
When treatment follows administration  of a  monoamine oxidase  inhibitor,  in 
both cases again,  agitation replaces sedation, and  a fall in body temperature 
is replaced by a  rise, 
DISCUSSION 
Reserpine protects mice from anaphylactic  shock  (6,  7)  and  also releases 
serotonin and catechol amines (28). We have confirmed the ability of reserpine 
to protect mice and have found that the protection is maximal when the drug 
is given 2 days and again  1 day prior to challenge  with antigen,  but is non- 
existent when reserpine is given 30 minutes prior to Challenge. The protection 
by reserpine is therefore a delayed phenomenon and is probably not due to a 
direct action of the drug itself.  It seems likely that the delay may be needed 
for the slow process of amine depletion, fl-TM10, a member of a series of drugs 
which prevent  the release  of catechol amines  from sympathetic nerves  and 
deplete catechol amines from the adrenal  medulla  (29,  30),  did not protect 
mice from anaphylactic  shock.  Since,  in addition,  epinephrine  (7),  and  nor- 
epinephrine do provide protection, it does not seem likely that catechol amine 
depletion by reserpine could be responsible for the ability of reserpine to pro- 
tect mice against anaphylactic shock. 
L-o~-methyl dopa, a  drug which will,  like  reserpine,  cause the depletion of 
serotonin, but which does so by a  different mechanism also protects against 
anaphylactic shock. It prevents serotonin synthesis by blocking the decarboxyl- 
ation  of 5-hydroxytryptophane  (32-34).  Reserpine interferes  with  serotonin 
binding by tissues (28) leading to the release  of serotonin and its subsequent 
metabolism by monoamine oxidase. Since these two drugs have little in common 
besides the ability to cause amine depletion, yet both protect mice from ana- 
phylacric shock, it seems reasonable that the common action would probably 
be responsible for  the protection in  both  cases.  In  addition,  since  catechol 
amine depletion is unlikely to provide protection, these findings may be taken 
as evidence that the presence of serotonin is necessary for anaphylactic shock 
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The enterochromaffin cell population of the mouse duodenum was  studied 
because  there  is  a  considerable  amount  of evidence  (14-18)  indicating  that 
these cells represent a serotonin depot. Enterochromaffin substance was severely 
depleted by anaphylactic shock. Nonspecific stresses, such as lethal histamine, 
or 48/80 administration, or the subjection of mice to cold, fatigue, and drown- 
ing did not release enterochromaffin substance. This finding is consistent with 
the hypothesis that serotonin is released from these cells in anaphylactic shock. 
Reserpine, which protects against anaphylactic shock and releases serotonin, 
also depletes enterochromaffin substance. When, after the injection of reserpine, 
the number of enterochromaffin cells is low, as after 48 hours, mice are refrac- 
tory to anaphylactic shock. However, as the enterochromaffm cell population 
recovers from the injection of reserpine, as it has largely done after 108 hours, 
the susceptibility of mice to anaphylactic shock similarly returns. Analyses of 
intestinal  serotonin have  also  returned  nearly to  control levels at  this  time 
(14, 28). The protection from anaphylactic shock may be maintained, however, 
if animals  are prevented by L-a-methyl dopa from resynthesizing serotonin. 
The state of the enterochromaffin cell population thus seems to correlate well 
with the susceptibility of mice to anaphylactic shock. 
It was  unexpectedly found that  serotonin, like reserpine and  anaphylaxis, 
causes  the  depletion of  enterochromaffln substance.  If  the  enterochromaffin 
cells do contain serotonin, then serotonin must be viewed as being able to cause 
its own release and depletion. Consistent with this view is the fact that sub- 
lethal doses of serotonin protect mice from anaphylactic shock. While incom- 
plete protection follows 3 hours after an injection of serotonin, complete pro- 
tection is seen after 4 hours. Most likely, time is needed for serotonin metabo- 
lism, after the injection of serotonin, before protection can be afforded. This 
finding at first seems to conflict with the hypothesis that anaphylactic shock 
is due to serotonin release. It would seem that if serotonin were the cause of 
anaphylactic shock,  then doses of serotonin should  add  to  endogenous sero- 
tonin,  released  by  antigen,  thereby  increasing,  rather  than  decreasing  the 
susceptibility of mice to anaphylactic shock. The resolution of this apparent 
paradox was thought probably to lie in the timing of the administration of the 
drugs. When doses of antigen precede doses of serotonin, the effects are additive 
and the toxicity of the serotonin is enhanced as would be expected if antigen 
causes the release of serotonin. But when serotonin was given before a dose of 
antigen,  and  time  was  permitted  for  its  breakdown,  enterochromaffin cell 
depletion occurs, and we may postulate therefore that a depot of serotonin no 
longer remains to be released by antigen.  Consequently, when the drugs are 
given in this way serotonin protects against anaphylactic shock. 
Since  enterochromaffin substance  is  released  in  anaphylactic  shock,  two 
independent lines of inductive evidence are thus brought together. One indi- 
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and the other indicates that serotonin is released and plays a role in anaphylac- 
tic shock. Both lines of evidence are supported by this study, and indeed each 
now provides support for the other. As is always the case in an inductive argu- 
ment, however, uncertainty remains.  Future studies of a  more direct nature 
will be necessary, but  the  definite establishment  of one of these points  will 
provide evidence in favor of the other. 
There is a  strong similarity between the behavior of mice given reserpine, 
and those undergoing anaphylactic shock. Both groups of animals show seda- 
tion during at least one phase of treatment, and both show a fall in body tem- 
perature. More importantly however, the effect of monoamine oxidase inhibi- 
tion on anaphylactic shock is also similar to the effect of monoamine oxidase 
on reserpine treatment.  In both cases depression is replaced by agitation.  In 
both cases a  fall in body temperature is replaced by a  rise. The agitated be- 
havior that follows monoamine oxidase inhibition in both cases is also similar 
to that  seen following monoamine oxidase inhibition and  the administration 
of 5-hydroxytryptophane, which raises brain serotonin levels. It has been pro- 
posed that sedation after reserpine administration is due to serotonin release 
(28, 39), and that the agitation that follows, when reserpine is combined with 
monoamine  oxidase inhibitor,  is  due  to  the  resultant  high  concentration  of 
free  serotonin  in  the  brain  (42,  43).  Therefore,  the  similarity  between  the 
behavioral  effects of anaphylactic  shock  and  reserpine raises  the  possibility 
that serotonin release is a  common feature, responsible for the effects in both 
cases. These behavioral findings, when reviewed along with the other evidence 
presented  above,  support  the  hypothesis  that  serotonin  release  is  causally 
related to anaphylactic shock. 
SUMMARY 
Protection against anaphylactic shock in mice by reserpine  has been shown 
to be a delayed phenomenon,  probably not dependent upon a direct  effect  of 
reserpine. The release and depletion of catechol amines by reserpine show 
little  likelihood of being responsible for protection because  these substances 
are in  themselves protective  against  anaphylactic shock, while/3-TM 10, a drug 
which interferes  with their  release  is not. Since  L-s-methyl dopa and reserpine 
both deplete serotonin,  and since  both protect against anaphylactic shock, it  is 
proposed that serotonin depletion is responsible  for the protection. 
Enterochromaffin  substance  is depleted in anaphylactic  shock. It is also 
depleted by reserpinc  and serotonin,  both of which protect  against  anaphylactic 
shock when  given prior to challenge with antigen. The  amount  of entero- 
chromaffin substance  seems to correlate with susceptibility to anaphylactic 
shock. 
The behavior  of animals undergoing anaphylactic shock and the effect  of 
shock on body temperature is  similar  to the effects  on behavior and temperature 380  5-HYDROXYTRYPTAM~IVE IN  M'OUSE ANAPHYLAXIS 
of treatment with reserpine, which is known to release serotonin. The effect of 
monoamine  oxidase inhibition  on  animals  undergoing  anaphylactic  shock  is 
also  similar to  the  effect of monoamine oxidase inhibition  on animals given 
reserpine. 
These results are consistent with the views that the release of serotonin is 
causally related to anaphylactic shock in mice and that serotonin is accumu- 
lated in the chromogenic material of the enterochromaffin cell. 
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EXPLANATION OF PLATE 37 
FIG. 1. A low power micrograph of a portion of the duodenum of a normal mouse. 
The enterochromaffin cells are stained black. Methenamine silver method, neutral  red 
counterstain.  8  micra section thickness.  X  300. 
FIG. 2. A lower power micrograph of a portion of the duodenum  of a  mouse sub- 
jected  to  anaphylactic  shock.  The enterochromaffin cells,  stained  black,  are few in 
number.  Methenamine  silver  method,  neutral  red  counterstain.  8  micra  section 
thickness.  X  300. THE  JOURNAL  OF  EXPERIMENTAL  MEDICINE  VOL. 115  PLATE 37 
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